Cargando…

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients

PURPOSE: To compare the endocrine and metabolic indexes of obese and normal body mass index (BMI) polycystic ovary syndrome (PCOS) patients, and explore factors affecting the pathogenesis and progression of PCOS. METHODS: This study included obese (n=79) and normal BMI (n=40) PCOS patients, and obes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Wenjing, Zhao, Qi, Zhao, Xue, Xing, Chuan, He, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526511/ https://www.ncbi.nlm.nih.gov/pubmed/34703260 http://dx.doi.org/10.2147/DMSO.S329108

Ejemplares similares

Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome
por: Li, Chunzhu, et al.
Publicado: (2021)

Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol
por: Zhang, Jiaqi, et al.
Publicado: (2022)

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients
por: Günday, Özlem Kayacık, et al.
Publicado: (2023)

Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity
por: Neven, Adriana C. H., et al.
Publicado: (2023)

Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial
por: Zhang, Jiaqi, et al.
Publicado: (2022)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome
por: Pokorska-Niewiada, Kamila, et al.
Publicado: (2022)

Insulin level, lipid profile, and HOMA index in lean and obese patients with polycystic ovary syndrome
por: Hussein, Shamim Riadh Mohammed, et al.
Publicado: (2023)

Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome
por: Kumar, Amar Nagesh, et al.
Publicado: (2016)

Time-restricted feeding improves metabolic and endocrine profiles in mice with polycystic ovary syndrome
por: Han, Yan, et al.
Publicado: (2022)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
por: Wang, Dongxu, et al.
Publicado: (2023)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
por: Couto Alves, A, et al.
Publicado: (2017)

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients
por: Layegh, Parvin, et al.
Publicado: (2016)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2017)

Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
por: Agacayak, Elif, et al.
Publicado: (2015)

Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates
por: Akın, Leyla, et al.
Publicado: (2020)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Racial and Ethnic Differences in Metabolic Disease in Adolescents With Obesity and Polycystic Ovary Syndrome
por: Andrisse, Stanley, et al.
Publicado: (2021)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Common endocrine disorders associated with the polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2021)

Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome
por: Zhang, Chun-mei, et al.
Publicado: (2014)

Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
por: Chen, Huize, et al.
Publicado: (2023)

Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice
por: Ande, Sudharsana Rao, et al.
Publicado: (2017)

Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?
por: Dube, Rajani
Publicado: (2016)

Renal resistive index in patients with polycystic ovary syndrome
por: Tüfekçioğlu, Gülsen, et al.
Publicado: (2019)

The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome
por: Usta, Akin, et al.
Publicado: (2018)

Polycystic Ovary Syndrome and Obesity: A Cross-Sectional Survey of Patients and Obstetricians/Gynecologists
por: Gill, Lisa, et al.
Publicado: (2023)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome
por: Satyaraddi, Anil, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5obp81tqq0lpd8jvbtkhrjdr3e